Furthermore, the inhibition of myostatin reduces bone destruction caused by osteoarthritis, so myostatin could be a target for treating osteoarthritis (Bray, 2015; Dankbar et al., 2015; Onuora, 2015). This evidence concerns the gene MSTN and osteoarthritis.